Trexquant Investment LP - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 100 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q4 2021$186,000
+19.2%
34,809
+171.4%
0.01%
-15.4%
Q2 2021$156,000
-45.3%
12,826
+9.2%
0.01%
-50.0%
Q1 2021$285,000
-15.4%
11,748
+11.6%
0.03%
-27.8%
Q4 2020$337,00010,5290.04%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q3 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders